Evan Smith - Concepedia

Author

Evan Smith

Pfizer (United States)

Also Known As

E Smith, E. F. SMITH III, Evan C. Smith, Evan Smith

Publications

824

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Neurocrine Biosciences (United States)

About

Evan Smith is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	359
2	Biochemistry	4	4	315
3	Natural Sciences	2	2	96
4	Health Sciences	1	1	183
5	Social Sciences	1	1	36

Evan Smith

Publications

814

Citations

H-Index

Page 1

	Year	Citations
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites Dimitri E. Grigoriadis, Evan Smith, Sam R.J. Hoare, Journal of Pharmacology and Experimental Therapeutics	2017	252
Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating Metabolites Deepak Dalvie, R. Scott Obach, Ping Kang, Chemical Research in Toxicology Circulating MetabolitesMetabolomic ProfilingSecondary MetaboliteMetabolic ModelVitro Systems	2009	183
Identifying a Selective Substrate and Inhibitor Pair for the Evaluation of CYP2J2 Activity Caroline A. Lee, J. P. Jones, Jonathan Katayama, Drug Metabolism and Disposition	2012	92
Bioactivation of Lumiracoxib by Peroxidases and Human Liver Microsomes: Identification of Multiple Quinone Imine Intermediates and GSH Adducts Ping Kang, Deepak Dalvie, Evan Smith, Chemical Research in Toxicology Lipid PeroxidationPharmacotherapyRedox BiologyPharmaceutical ChemistryToxicological Mechanism	2008	54
Bioactivation of Flutamide Metabolites by Human Liver Microsomes Ping Kang, Deepak Dalvie, Evan Smith, Drug Metabolism and Disposition	2008	49
A phase I, open-label, mass balance study of [14C] dacomitinib (PF-00299804) in healthy male volunteers Carlo L. Bello, Evan Smith, Ana Ruiz-Garcı́a, Cancer Chemotherapy and Pharmacology MedicineMass Balance StudyHealthy Male VolunteersPharmacology	2013	44
Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1<i>H</i>-pyrazol-1-yl)ethoxy]-6-methylphenyl}-<i>N</i>-(2,2-difluoropropyl)-5,7-dihydro-6<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxamide Luke R. Zehnder, Michael J. Bennett, Jerry Meng, Journal of Medicinal Chemistry Pharmaceutical ScienceDevelopment CandidatePharmacotherapyPharmaceutical ChemistryTumor Biology	2011	42
Identification of a Novel Glutathione Conjugate of Flutamide in Incubations with Human Liver Microsomes Ping Kang, Deepak Dalvie, Evan Smith, Drug Metabolism and Disposition	2007	41
Pharmacokinetics of monoamine oxidase inhibitors. Alan G. Mallinger, Evan Smith PubMed PsychopharmacologyPharmacotherapyExperimental PharmacologySocial SciencesMolecular Pharmacology	1991	36
IN VITRO METABOLIC ACTIVATION OF THIABENDAZOLE VIA 5-HYDROXYTHIABENDAZOLE: IDENTIFICATION OF A GLUTATHIONE CONJUGATE OF 5-HYDROXYTHIABENDAZOLE Deepak Dalvie, Evan Smith, Alan Deese, Drug Metabolism and Disposition	2006	21

Page 1